Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

Presentation TCT 2025

TCT 541: Left Bundle Branch Area Pacing Is Non Inferior To CRT Pacing in Heart Failure with Reduced LVEF, 7 years Follow Up Study From Eastren India

Presenter: Sudeb Mukherjee

October 27, 2025

Presentation TCT 2016

Coronary Venous Angioplasty for CRT-D LV Lead Placement

Presenter: George D. Dangas, Arindam Pande

October 31, 2016

Presentation TCT 2016

Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial?

Presenter: Ted Feldman, Allan Schwartz, JoAnn Lindenfeld

October 30, 2016

Presentation TCT 2015

How Effective Is CRT in Reducing MR?

Presenter: Patrick T. O'Gara, Allan Schwartz, William T. Abraham

October 11, 2015

Presentation TCT 2013

CRT in Functional MR: Yes, the Prognosis Is Poor in Nonresponders, but Is This a Valid Upfront Therapeutic Option?

Presenter: Matthew Reynolds

October 28, 2013

Presentation TCT 2012

Updated CRT Guidelines

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

Follow the (Lack of) Evidence: Medical Therapy and CRT!

Presenter: Allan Schwartz

October 23, 2012

Presentation TCT 2012

CRT Applicability in Key Subgroups: Earlier (NYHA I/II), Later (NYHA IV), and Female Patients

Presenter: Kimberly Selzman

October 23, 2012

Presentation TCT 2012

CRT in the Management of the Patient with Heart Failure and Severe MR

Presenter: William Abraham

October 23, 2012

Presentation TCT 2012

Prognosis of chronic hemodialysis patients with crtical limb ischemia after isolated infrapopliteal balloon angioplasty from the J-BEAT registry

Presenter: Masatsugu Nakano

January 03, 2012

Advertisement

TCT 541: Left Bundle Branch Area Pacing Is Non Inferior To CRT Pacing in Heart Failure with Reduced LVEF, 7 years Follow Up Study From Eastren India

Coronary Venous Angioplasty for CRT-D LV Lead Placement

Medical Therapy, Revascularization, and CRT for Functional Mitral Regurgitation: Despite Class I Guidelines, Are the Benefits Substantial?

How Effective Is CRT in Reducing MR?

CRT in Functional MR: Yes, the Prognosis Is Poor in Nonresponders, but Is This a Valid Upfront Therapeutic Option?

Updated CRT Guidelines

Follow the (Lack of) Evidence: Medical Therapy and CRT!

CRT Applicability in Key Subgroups: Earlier (NYHA I/II), Later (NYHA IV), and Female Patients

CRT in the Management of the Patient with Heart Failure and Severe MR

Prognosis of chronic hemodialysis patients with crtical limb ischemia after isolated infrapopliteal balloon angioplasty from the J-BEAT registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content